Results 31 to 40 of about 1,247,370 (242)

Patient/Family Education for Newly Diagnosed Pediatric Oncology Patients [PDF]

, 2016
There is a paucity of data to support evidence-based practices in the provision of patient/family education in the context of a new childhood cancer diagnosis.
Ahern, JoAnn, Barakat, Lamia P., Bhatia, Smita, Bingen, Kristin M., Bondurant, Patricia G., Cohn, Susan L., Dobrozsi, Sarah K., Haugen, Maureen, Herring, Ruth Anne, Hockenberry, Marilyn, Hooke, Mary C., Landier, Wendy, Martin, Melissa, Murphy, Kathryn, Newman, Amy R., Rodgers, Cheryl C., Ruccione, Kathleen S., Sullivan, Jeneane, Weiss, Marianne E., Withycombe, Janice, Yasui, Lise   +20 more
core   +1 more source

Work stress and cancer researchers : an exploration of the challenges, experiences and training needs of UK cancer researchers. [PDF]

, 2014
Work stress is a significant issue for many UK healthcare professionals, in particular those working in the field of oncology. However, there have been very few attempts to explore the challenges, experiences or training needs of researchers working in ...
Barnard, Cannon, Chiang, Dickson-Swift, Dickson-Swift, Dickson-Swift, Fallowfield, Gibson, Gilbert, Girgis, Graham, Grunfeld, Henderson, Hochschild, Howard, Johnson, Johnson, Jones, Kendall, Kidd, Kovács, Książek, Lalor, Le Blanc, Mackay, Mann, Mann, Maslach, Mason, Nutov, Pugliesi, Rager, Ramirez, Silverman, Trufelli, Turner, Zammuner, Zapf   +37 more
core   +1 more source

Unlocking the potential of tumor‐derived DNA in urine for cancer detection: methodological challenges and opportunities

Molecular Oncology, EarlyView.
Urine is a rich source of biomarkers for cancer detection. Tumor‐derived material is released into the bloodstream and transported to the urine. Urine can easily be collected from individuals, allowing non‐invasive cancer detection. This review discusses the rationale behind urine‐based cancer detection and its potential for cancer diagnostics ...
Birgit M. M. Wever, Renske D. M. Steenbergen   +1 more
wiley   +1 more source

Ablative therapy for people with localised prostate cancer : a systematic review and economic evaluation [PDF]

, 2015
The research reported in this issue of the journal was funded by the HTA programme as project number 10/136/01. The contractual start date was in April 2012.
, , , Ahmed, Ahmed, Aitkenhead, Albertsen, Albertsen, Alemozaffar, Allen, Anandadas, Andriole, Arvold, Ashman, Bahn, Barret, Bart, Bayoumi, Bellardita, Beyer, Bhatnagar, Bill-Axelson, Blana, Blana, Boettcher, Boorjian, Borchers, Bosanquet, Bott, Bradley, Breyer, Brown, Bul, Burdick, Buron, Caso, Caso, Chamberlain, Chaussy, Chen, Chin, Ciezki, Coen, Cohen, Cohen, Cohen, Collins, Colombel, Cooperberg, Corwin, Cowen, Cox, Crook, Cytron, Dall’Era, Darras, De la Rosette, Dindo, Donnelly, Donnelly, Downs, Draisma, D’Amico, D’Amico, D’Amico, Eade, Eggener, El Fegoun, Elliott, Ellis, Epstein, Ferrer, Ficarra, Fourcade, Frank, Ganzer, Ganzer, Gardner, Gheiler, Giberti, Gleason, Godtman, Goldner, Goldner, Guedea, Hale, Han, Hardie, Heidenreich, Helpap, Hilton, Hoffmann, Hubosky, Hummel, Illing, Iman, Iman, Inoue, Ito, Jackson, Jani, Jemal, Johansson, Kattan, Kattan, Kibel, Kirschner-Hermanns, Klotz, Klotz, Klotz, Kobayashi, Kobuke, Koch, Korfage, Krahn, Kupelian, Lambert, Lane, Leal, Lee, Lee, Lepor, Lian, Lindner, Lindner, Litwin, Litwin, Loblaw, Mack, Maclennan, Maestroni, Malcolm, Marberger, Martinez, McNichols, Mearini, Merrick, Misrai, Mohamed, Mohammed, Neerhut, Nepple, Onik, Onik, Pardo, Paulson, Paulson, Pe, Pickles, Pinkawa, Pinthus, Poissonnier, Polascik, Potosky, Prentis, Rabbani, Ramsay, Raut, Reeve, Resnick, Roach, Robinson, Robinson, Robinson, Robinson, Ruchlin, Saliken, Salomon, Samaratunga, Sanda, Sandblom, Schroder, Seabra, Selvadurai, Shah, Shao, Shariat, Shelley, Shimizu, Shoji, Smith, Smith, Sobin, Sommers, Spiegelhalter, Stark, Stattin, Steginga, Stewart, Sumitomo, Sutton, Svatek, Svatek, Swartzman, Talcott, Tangen, Tefilli, Thompson, Thuroff, Tierney, Tosoian, Truesdale, Tsui, Uchida, Uchida, Uchida, Uchida, Uchida, Uchida, van As, van den Bergh, van den Bergh, van der Kwast, Van Der Poel, van Hout, Vasarainen, Vassil, Verhagen, Vicini, Vogl, Vose, Ward, Ware, Wei, Welch, Weldon, Williams, Wilt, Wong, Wong, Zelefsky, Zelefsky, Zeliadt, Zietman   +233 more
core   +3 more sources

Subpar reporting of pre‐analytical variables in RNA‐focused blood plasma studies

Molecular Oncology, EarlyView.
Pre‐analytical variables strongly influence the analysis of extracellular RNA (cell‐free RNA; exRNA) derived from blood plasma. Their reporting is essential to allow interpretation and replication of results. By evaluating 200 exRNA studies, we pinpoint a lack of reporting pre‐analytical variables associated with blood collection, plasma preparation ...
Céleste Van Der Schueren, Philippe Decruyenaere, Francisco Avila Cobos, Johanna Bult, Jill Deleu, Laudonia Lidia Dipalo, Hetty Hilde Helsmoortel, Eva Hulstaert, Annelien Morlion, Elena Ramos Varas, Kathleen Schoofs, Wim Trypsteen, Eveline Vanden Eynde, Hanne Van Droogenbroeck, Kimberly Verniers, Jo Vandesompele, Anneleen Decock   +16 more
wiley   +1 more source

Ex Vivo Metrics™, a preclinical tool in new drug development [PDF]

, 2008
Among the challenges facing translational medicine today is the need for greater productivity and safety during the drug development process. To meet this need, practitioners of translational medicine are developing new technologies that can facilitate ...
Gabbert, Helmut (Department of Pathology), Geddert, Helene (Department of Pathology), Haas, Rainer (Department of Hematology, Oncology and Clinical Immunology), Kronenwett, Ralf (Department of Hematology, Oncology and Clinical Immunology), Neukirchen, Judith (Department of Hematology, Oncology and Clinical Immunology), Pardillos, Guillermo (Department of Hematology, Oncology and Clinical Immunology), Pitschke, Gerald (Max F. Perutz Laboratories), Rohr, Ulrich-Peter (Department of Hematology, Oncology and Clinical Immunology), Rohrbeck, Astrid (Department of Hematology, Oncology and Clinical Immunology), Rosskopf, Michael (Institute for Bioinformatics), Schott, Matthias (Department of Endocrinology, Diabetology and Rheumatology), Schwalen, Andreas (Department of Cardiology, Pneumology and Angiology), von Haeseler, Arndt (University of Vienna)   +12 more
core   +2 more sources

Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients

Molecular Oncology, EarlyView.
Cancer‐associated fibroblasts (CAFs) promote cancer growth, invasion (metastasis), and drug resistance. Here, we identified functional and diverse circulating CAFs (cCAFs) in patients with metastatic prostate cancer (mPCa). cCAFs were found in higher numbers and were functional and diverse in mPCa patients versus healthy individuals, suggesting their ...
Richell Booijink, Leon W. M. M. Terstappen, Eshwari Dathathri, Khrystany Isebia, Jaco Kraan, John Martens, Ruchi Bansal   +6 more
wiley   +1 more source

Molecular Diagnostics in Clinical Oncology

Frontiers in Molecular Biosciences, 2018
There are multiple applications of molecular tests in clinical oncology. Mutation analysis is now routinely utilized for the diagnosis of hereditary cancer syndromes. Healthy carriers of cancer-predisposing mutations benefit from tight medical surveillance and various preventive interventions.
Anna P. Sokolenko, Anna P. Sokolenko, Evgeny N. Imyanitov, Evgeny N. Imyanitov, Evgeny N. Imyanitov, Evgeny N. Imyanitov   +5 more
openaire   +4 more sources

Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells

Molecular Oncology, EarlyView.
In the era of immunotherapies, many patients either do not respond or eventually develop resistance. We propose to pave the way for proteomic analysis of surface‐expressed proteins called surfaceome, of circulating tumor cells. This approach seeks to identify immune evasion mechanisms and discover potential therapeutic targets. Circulating tumor cells (
Doryan Masmoudi, Jérome Vialaret, Christophe Hirtz, Catherine Alix‐Panabières   +3 more
wiley   +1 more source

The management of clinical emergencies in oncology

European Journal of Cancer Supplements, 2007
The incidence of cancer is remaining constant or slightly increasing in Europe. Due to screening programmes and better multi-modality treatment, the prevalence of cancer is significantly increasing. In addition, the aging population in Europe is rapidly rising.
Hoekstra, H.J., Wobbes, T.
openaire   +4 more sources